Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Non-Current Assets (2016 - 2025)

Cosmos Health's Non-Current Assets history spans 13 years, with the latest figure at $27.1 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $27.1 million for Q4 2025, down 6.1% from a year ago — trailing twelve months through Dec 2025 was $119.1 million (up 5.77% YoY), and the annual figure for FY2025 was $27.1 million, down 6.1%.
  • Non-Current Assets for Q4 2025 was $27.1 million at Cosmos Health, down from $31.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $31.4 million in Q3 2025 to a low of $2.8 million in Q2 2021.
  • The 5-year median for Non-Current Assets is $24.7 million (2023), against an average of $19.1 million.
  • The sharpest move saw Non-Current Assets surged 269.73% in 2023, then dropped 6.1% in 2025.
  • Year by year, Non-Current Assets stood at $9.6 million in 2021, then increased by 21.63% to $11.7 million in 2022, then soared by 151.95% to $29.4 million in 2023, then fell by 1.89% to $28.9 million in 2024, then dropped by 6.1% to $27.1 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $27.1 million, $31.4 million, and $31.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.